Skip to main content
. 2018 Nov 14;5(11):181457. doi: 10.1098/rsos.181457

Figure 1.

Figure 1.

Factors influencing the formulation properties of RSV-PLGA-NPs. (a) 50 mg PLGA versus 8 mg RSV, 4 h of stirring time; (b) 50 mg PLGA versus 10 mg RSV, 10 ml of BSA solution, 4 h of stirring time; (c) 50 mg PLGA versus 10 ml of BSA solution, 4 h of stirring time; (d) 50 mg PLGA versus 9 mg RSV, 10 ml of BSA solution.